HF
KPRX icon

HRT Financial’s Kiora Pharmaceuticals KPRX Stock Holding History

HRT Financial’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,540
Closed -$16K – 2676
2024
Q1 		$16K Buy
+2,540
New +$14.2K ﹤0.01% 2027
2023
Q3 		– Sell
-1,497
Closed -$8K – 2769
2023
Q2 		$8K Buy
+1,497
New +$31.4K ﹤0.01% 2188
2021
Q4 		– Sell
-28
Closed -$22K – 3651
2021
Q3 		$22K Buy
+28
New +$23.8K ﹤0.01% 3140

Other funds holding KPRX

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HRT Financial's KPRX Position: Q2 2024 in Review

HRT Financial sold out of Kiora Pharmaceuticals (KPRX) in Q2 2024, closing a stake of 2,540 shares — an estimated $16K sold.

HRT Financial first reported a position in KPRX in Q3 2021 and held it in 3 quarters. The position peaked at $22K in Q3 2021. 17 funds tracked by Wall St. Rank hold KPRX as of Q2 2024.

  • HRT Financial reported no remaining Kiora Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • HRT Financial sold 2,540 Kiora Pharmaceuticals shares in Q2 2024, an estimated $16K.
  • HRT Financial first reported a position in Kiora Pharmaceuticals in Q3 2021 and held it in 3 quarters.
  • HRT Financial's Kiora Pharmaceuticals position peaked at $22K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q2 2024.

Based on HRT Financial's 13F filing for Q2 2024, filed 12 Aug 2024.